Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ore Holdings Inc (ORXE)

Ore Holdings Inc (ORXE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,058
  • Shares Outstanding, K 5,470
  • Annual Sales, $ 0 K
  • Annual Income, $ -290 K
  • 60-Month Beta 1.20
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ORXE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.01
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 09/29/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1921 +0.68%
on 07/13/17
0.1934 unch
on 08/08/17
+0.0034 (+1.79%)
since 07/07/17
3-Month
0.1200 +61.17%
on 06/16/17
0.1934 unch
on 08/08/17
+0.0734 (+61.17%)
since 04/03/17
52-Week
0.0700 +176.29%
on 11/16/16
0.4545 -57.45%
on 12/02/16
+0.1204 (+164.93%)
since 07/12/16

Business Summary

Ore Holdings, Inc. is engaged in developing and monetizing pharmaceutical assets, which includes compounds in-licensed from major pharmaceutical companies. Its compounds are used in treating Inflammatory Bowel Disease and other gastrointestinal indications; inflammatory and autoimmune diseases, cardiovascular...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.1934
1st Resistance Point 0.1934
Last Price 0.1934
1st Support Level 0.1934
2nd Support Level 0.1934
3rd Support Level N/A

See More

52-Week High 0.4545
Fibonacci 61.8% 0.3076
Fibonacci 50% 0.2623
Fibonacci 38.2% 0.2169
Last Price 0.1934
52-Week Low 0.0700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar